维普期刊资源整合服务平台（V6.5）

29篇 您的检索式：作者名="Wikstrand CJ"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	EGFRvⅢ as a promising target for antibody-based brain tumor therapy显示文摘	Kuan CT Wikstrand CJ Bigner DD	2000	Brain Tumor Pathol2000，17，2：	1
2	EGF mutant receptor will as a molecular target in cancer therapy显示文摘	Kuan CT Wikstrand CJ Bigner DD	2001	Endoct Relat Cancer2001，8，：	1
3	Increased binding affinity enhances targeting of glioma xenografts by EGFR Ⅷ speeific ScFv显示文摘	Kuan CT wikstrand CJ Archer G	2000	Int J cancer2000，88，6：	1
4	Generation of anti-idiotypic reagents in the EGFRvⅢ tumor-associated antigen system显示文摘	Wikstrand CJ Cole VR Crotty LE	2002	Cancer Immunol Immunother2002，50，12：	1
5	Resistance to tyrosine kinase inhibition by mutant epidermal growth fac-tor receptor variantⅢcontributes to the neoplastic phe-notype of glioblastoma multiforme显示文摘	Learn CA Hartzell TL Wikstrand CJ	2004	Clin Cancer Res2004，10，9：	1
6	Receptor dimerization is not a factor in the signalling activity of a transforming variant epidermal growth factor receptor (EGFRvⅢ)显示文摘	Chu CT Everiss KD Wikstrand CJ	1997	Biochem J1997，324，3：	1
7	EGF mutant receptor v III as a molecular target in cancer therapy显示文摘	Kuan CT Wikstrand CJ Bigner DD	2001	Endocr Relat Cancer2001，8，2：	1
8	The class III variant of the epidermal growth factor receptor(EGFRvIII):characterization and utilization as an immunotherapeutic target显示文摘	Wikstrand CJ Reist CJ Archer GE	1998	J Neurovirolt1998，4，2：	1
9	Resistance to tyro-sine kinase inhibition by mutant epidermal growth factor receptorvariant III contributes to the neoplastic phenotype of glioblastomamultiforme显示文摘	Learn CA Hartzell TL Wikstrand CJ	2004	Clin Cancer Res2004，10，：	1
10	C-reactive pro- tein and tumor necrosis factor-alpha in relation to insulin- mediated glucose uptake, smoking and atherosclerosis显示文摘	Fagerberg B Behre CJ Wikstrand J	2008	Scand J Clin Lab Invest2008，68，7：	1
11	Resistance to tyrosine kinase inhibition by mutant epidermal growth factor receptor variant Ⅲ contributes to the neoplastic phenotype of glioblastoma multiforme显示文摘	Learn CA Hartzell TL Wikstrand CJ	2004	Clinical Cancer Res2004，10，9：	1
12	EGF mutant receptor vIII as a molecular target in cancer therapy显示文摘	Kuan CT Wikstrand CJ Bigner DD	2001	Endocr Relat Cancer2001，8，2：	1
13	Mouse/human chimeric Mel-14 antibody:genomic cloning of the variable region genes,linkage to human constant region genes,expression,and characterization显示文摘	Batra SK Niswonger ML Wikstrand CJ		0，，02：	1
14	EGF mutant receptor v Ⅲ as a molecular target in cancer therapy显示文摘	Kuan CT Wikstrand CJ Bigner DD	2001	Endocr Relat Cancer2001，8，2：	1
15	Resistance to tyrosine kinase inhibition by mutant epidermal growth factor receptor variant Ⅲ contributes to the neoplastic phenotype of glioblastoma multiforme显示文摘	Learn CA Hartzell TL Wikstrand CJ	2004	Clin Cancer Res2004，10，9：	1
16	Resistance to tyrosine kinase inhibition by mutant epidermal growth factor receptor variant ill contributes to the neoplastic phenotype of glioblastoma multiforme显示文摘	Learn CA Hartzell TL Wikstrand CJ	2004	Clin Cancer Res2004，10，9：	1
17	Creactive pro rein and tumor necrosis factor-alpha in relation to insulin- mediated glucose uptake, smoking and atherosclerosis显示文摘	Fagerberg B Behre CJ Wikstrand J	2008	Stand J Clin Lab Invest2008，68，7：	1
18	Epidermal growth factor ligand-independent, unregulated, cell transforming potential of a naturally occurring human mutant EGFRv gene 显示文摘	Castelino-Prabhu S Wikstrand CJ	1995	Cell Growth Differ1995，6，10：	1
19	EGF mutant receptor v as a moleculor target in cancer therapy 显示文摘	Kuan CT Wikstrand CJ	2001	Endocr Relat Cancer2001，8，2：	1
20	EGFRvⅢ as a promising target for antibody-based brain tumor therapy显示文摘	Kuan CT Wikstrand CJ Bigner DD	2000	Brain Tumor Pathol2000，17，2：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示